Publication
Invasive Bacterial Infections in Children With Sickle Cell Disease: 2014–2019
dc.contributor.author | Gaschignard, J | |
dc.contributor.author | Koehl, B | |
dc.contributor.author | Rees, DC | |
dc.contributor.author | Rincón-López, E | |
dc.contributor.author | Vanderfaeillie, A | |
dc.contributor.author | Pascault, A | |
dc.contributor.author | Allali, S | |
dc.contributor.author | Cela, E | |
dc.contributor.author | Odièvre, MH | |
dc.contributor.author | Hau, I | |
dc.contributor.author | Oliveira, M | |
dc.contributor.author | Guillaumat, C | |
dc.contributor.author | Brousse, V | |
dc.contributor.author | de Montalembert, M | |
dc.contributor.author | Navarro Gómez, ML | |
dc.contributor.author | Beldjoudi, N | |
dc.contributor.author | Bardon-Cancho, EJ | |
dc.contributor.author | Epalza, C | |
dc.contributor.author | Benkerrou, M | |
dc.contributor.author | Gaschignard, J | |
dc.contributor.author | Koehl, B | |
dc.contributor.author | Pascault, A | |
dc.contributor.author | Brousse, V | |
dc.contributor.author | Allali, S | |
dc.contributor.author | de Montalembert, M | |
dc.contributor.author | Odièvre, MH | |
dc.contributor.author | Hau, I | |
dc.contributor.author | Guillaumat, C | |
dc.contributor.author | Blais, S | |
dc.contributor.author | Runel-Belliard, C | |
dc.contributor.author | Pellegrino, B | |
dc.contributor.author | Malric, A | |
dc.contributor.author | Guitton, C | |
dc.contributor.author | Gouraud, F | |
dc.contributor.author | Petras, M | |
dc.contributor.author | Bensaid, P | |
dc.contributor.author | Basmaci, R | |
dc.contributor.author | Eyssette-Guereau, S | |
dc.contributor.author | Pham, LL | |
dc.contributor.author | Bardon-Cancho, EJ | |
dc.contributor.author | Cela, E | |
dc.contributor.author | Gómez, ML | |
dc.contributor.author | Rincon-Lopez, E | |
dc.contributor.author | Ruiz-Llobet, A | |
dc.contributor.author | Adan, R | |
dc.contributor.author | Puyo, PV | |
dc.contributor.author | Recasens, V | |
dc.contributor.author | Epalza, C | |
dc.contributor.author | Perez-Alonso, V | |
dc.contributor.author | Torrent, M | |
dc.contributor.author | Gomez, AB | |
dc.contributor.author | Vázquez, A | |
dc.contributor.author | Rodríguez, RP | |
dc.contributor.author | Alfaridi, H | |
dc.contributor.author | Almaghrabi, R | |
dc.contributor.author | Hoyoux, M | |
dc.contributor.author | Vanderfaeillie, A | |
dc.contributor.author | Ferreira, T | |
dc.contributor.author | Rees, D | |
dc.date.accessioned | 2024-02-27T11:09:26Z | |
dc.date.available | 2024-02-27T11:09:26Z | |
dc.date.issued | 2023 | |
dc.description.abstract | Background: Children with sickle cell disease (SCD) are at a high risk of invasive bacterial infections (IBI). Universal penicillin prophylaxis and vaccination, especially against Streptococcus pneumoniae, have deeply changed its epidemiology. Analysis of IBI in children with SCD in a post-13-valent pneumococcal vaccine era is limited. Methods: Twenty-eight pediatric hospitals from 5 European countries retrospectively collected IBI episodes in SCD children aged 1 month to 18 years between 2014 and 2019. IBI was defined as a positive bacterial culture or polymerase chain reaction from a normally sterile fluid: blood, cerebrospinal, joint, or pleural fluid and deep surgical specimen. Results: We recorded 169 IBI episodes. Salmonella spp. was the main isolated bacteria (n = 44, 26%), followed by Streptococcus pneumonia (Sp; n = 31, 18%) and Staphylococcus aureus (n = 20, 12%). Salmonella prevailed in osteoarticular infections and in primary bacteremia (45% and 23% of episodes, respectively) and Sp in meningitis and acute chest syndrome (88% and 50%, respectively). All Sp IBI occurred in children ≤10 years old, including 35% in children 5 to 10 years old. Twenty-seven (17%) children had complications of infection and 3 died: 2 because of Sp, and 1 because of Salmonella. The main risk factors for a severe IBI were a previous IBI and pneumococcal infection (17 Sp/51 cases). Conclusions: In a post-13-valent pneumococcal vaccine era, Salmonella was the leading cause of bacteremia in IBI in children with SCD in Europe. Sp came second, was isolated in children ≤10 years old, and was more likely to cause severe and fatal cases. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Pediatrics . 2023 Oct 1;152(4):e2022061061 | pt_PT |
dc.identifier.doi | 10.1542/peds.2022-061061 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.17/4817 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | American Academy of Pediatrics | pt_PT |
dc.subject | Sickle Cell Disease | pt_PT |
dc.subject | Invasive Bacterial Infections | pt_PT |
dc.subject | Child | pt_PT |
dc.subject | HDE HEM PED | pt_PT |
dc.title | Invasive Bacterial Infections in Children With Sickle Cell Disease: 2014–2019 | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.issue | 4 | pt_PT |
oaire.citation.startPage | e2022061061 | pt_PT |
oaire.citation.title | Pediatrics | pt_PT |
oaire.citation.volume | 152 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |